Molecular modeling studies of human immunodeficiency virus type 1 protease inhibitors using three‐dimensional quantitative structure‐activity relationship,virtual screening,and docking simulations

In this paper, two 3‐dimensional quantitative structure‐activity relationship models for 60 human immunodeficiency virus (HIV)‐1 protease inhibitors were established using random sampling analysis on molecular surface and translocation comparative molecular field vector analysis (Topomer CoMFA). The non–cross‐validation (r²), cross‐validation (q²), correlation coefficient of external validation (Q²_ext), and F of 2 models were 0.94, 0.80, 0.79, and 198.84 and 0.94, 0.72, 0.75, and 208.53, respectively. The results indicated that 2 models were reasonable and had good prediction ability. Topomer Search was used to search R groups in the ZINC database, 20 new compounds were designed, and the Topomer CoMFA model was used to predicate the biological activity. The results showed that 18 new compounds were more active than the template molecule. So the Topomer Search is effective in screening and can guide the design of new HIV/AIDS drugs. The mechanism of action was studied by molecular docking, and it showed that the protease inhibitors and Ile50, Asp25, and Arg8 sites of HIV‐1 protease have interactions. These results have provided an insight for the design of new potent inhibitors of HIV‐1 protease.     

Nano‐synthesis and spectral,thermal, modeling,quantitative structure–activity relationship and docking studies of novel bioactive homo‐binuclear metal complexes derived from thiazole drug for therapeutic applications

Seven novel homo‐binuclear Cr(III), Fe(III), Cu(II), ZrO(II), Sn(II), Pb(II) and Ce(III) nanosized complexes of a thiazole drug (H₂L) were synthesized for chemotherapeutic applications. H₂L was prepared via a condensation reaction between 2‐(4‐aminobenzenesulfonamido)thiazole and 2‐hydroxybenzaldehyde. The structures of H₂L and its metal complexes were investigated by various means. These included microanalysis, ¹H NMR, ¹³C NMR, Fourier transform infrared, UV–visible, electron spin resonance and mass spectroscopies, transmission electron microscopy (TEM), powder X‐ray diffraction (XRD), thermogravimetric analysis (TGA) and molar conductivity. The measurements revealed that H₂L coordinates with the metal ions through two chelating centers, indicating its behavior as a dibasic tetradentate ligand. The first center involves the nitrogen of azomethine (CH═N) and the α‐hydroxyl oxygen while the other center is the thiazole nitrogen and the sulfonamide oxygen. From spectroscopic and analytical data, the Cr(III), Fe(III) and Ce(III) complexes have octahedral geometries, whereas the Cu(II), ZrO(II), Sn(II) and Pb(II) complexes have tetrahedral geometries. TEM and XRD measurements unambiguously showed the nanometric particle sizes of the complexes. The activation thermo‐kinetic parameters, E*, ?H*, ?S* and ?G*, of the various decomposition steps of the complexes were determined mathematically from the TGA curves. Gaussian09 and quantitative structure–activity relationship modeling studies were utilized to verify the biological and structural feature relationships. Docking studies were performed to throw more light on the biological priority of the proposed drugs, using microorganism protein receptors. The antitumor and antimicrobial efficiencies of the H₂L drug and its complexes were determined to estimate their potential therapeutic utility. In general, the complexes showed greater antitumor and antimicrobial efficiencies than the H₂L drug. The Fe(III) complex exhibited efficient antimicrobial activities against Candida albicans and Staphylococcus aureus and its efficiency is equivalent to that of standard drugs. The Cu(II) complex showed the greatest cytotoxic activity towards HEPG2.     

Density functional theory/B3LYP study of nanometric 4‐(2,4‐dihydroxy‐5‐formylphen‐1‐ylazo)‐N‐(4‐methylpyrimidin‐2‐yl)benzenesulfonamide complexes: Quantitative structure–activity relationship,docking, spectral and biological investigations

New metal ion complexes were isolated after coupling with 4‐(2,4‐dihydroxy‐5‐formylphen‐1‐ylazo)‐N ‐(4‐methylpyrimidin‐2‐yl)benzenesulfonamide (H₂L) drug ligand. The structural and molecular formulae of drug derivative and its complexes were elucidated using spectral, analytical and theoretical tools. Vibrational spectral data proved that H₂L behaves as a monobasic bidentate ligand through one nitrogen from azo group and ionized hydroxyl oxygen towards all metal ions. UV–visible and magnetic moment measurements indicated that Fe(III), Cr(III), Mn(II) and Ni(II) complexes have octahedral configuration whereas Cd(II), Zn(II) and Co(II) complexes are in tetrahedral form. The Cu(II)complex has square planar geometry as verified through electron spin resonance essential parameters. X‐ray diffraction data indicated the amorphous nature of all compounds with no regular arrangement for the solid constituents during the precipitation process. Transmission electron microscopy images showed homogeneous metal ion distribution on the surface of the complexes with nanometric particles. Coats–Redfern equations were applied for calculating thermo‐kinetic parameters for suitable thermal decomposition stages. Gaussian09 and quantitative structure–activity relationship modelling studies were used to verify the structural and biological features. Docking study using microorganism protein receptors was implemented to throw light on the biological behaviour of the proposed drug. The investigated ligand and metal complexes were screened for their in vitro antimicrobial activities against fungal and bacterial strains. The resulting data indicated that the investigated compounds are highly promising bactericides and fungicides. The antitumour activities of all compounds were evaluated towards human liver carcinoma (HEPG2) cell line.